13D/13G Filings - Ultragenyx Pharmaceutical Inc. (RARE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-12
11:42 am
Purchase
2024-12-3113GUltragenyx Pharmaceutical Inc.
RARE
SANDS CAPITAL MANAGEMENT LLC4,298,003
4.700%
179,995increase
(+4.37%)
Filing
History
2025-02-10
10:25 am
Sale
2024-12-3113GUltragenyx Pharmaceutical Inc.
RARE
Wellington Management Group LLP2,457,543
2.700%
-1,957,486decrease
(-44.34%)
Filing
History
2024-11-14
06:42 am
Sale
2024-09-3013GUltragenyx Pharmaceutical Inc.
RARE
RTW INVESTMENTS LP1,968,002
2.100%
-4,919,084decrease
(-71.42%)
Filing
History
2024-02-14
10:03 am
Sale
2023-12-3113GUltragenyx Pharmaceutical Inc.
RARE
T. Rowe Price Associates, Inc.3,453,460
4.200%
-642,928decrease
(-15.69%)
Filing
History
2024-02-14
07:46 am
Purchase
2023-12-3113GUltragenyx Pharmaceutical Inc.
RARE
RTW INVESTMENTS LP6,887,086
8.400%
2,920,171increase
(+73.61%)
Filing
History
2024-02-13
5:16 pm
Purchase
2023-12-2913GUltragenyx Pharmaceutical Inc.
RARE
The Vanguard Group8,673,432
10.560%
1,436,909increase
(+19.86%)
Filing
History
2024-02-13
3:41 pm
Purchase
2023-12-3113GUltragenyx Pharmaceutical Inc.
RARE
SANDS CAPITAL MANAGEMENT LLC4,118,008
5.000%
4,118,008increase
(New Position)
Filing
History
2024-02-08
10:18 am
Sale
2023-12-2913GUltragenyx Pharmaceutical Inc.
RARE
Wellington Management Group LLP4,415,029
5.380%
-787,655decrease
(-15.14%)
Filing
History
2024-01-29
3:26 pm
Purchase
2023-12-3113GUltragenyx Pharmaceutical Inc.
RARE
BlackRock Inc.
BLK
5,238,400
6.400%
901,908increase
(+20.80%)
Filing
History
2023-09-11
1:33 pm
Purchase
2023-08-3113GUltragenyx Pharmaceutical Inc.
RARE
The Vanguard Group7,236,523
10.120%
862,293increase
(+13.53%)
Filing
History
2023-02-14
12:38 pm
Sale
2022-12-3113GUltragenyx Pharmaceutical Inc.
RARE
T. Rowe Price Associates, Inc.4,096,388
5.800%
-1,579,610decrease
(-27.83%)
Filing
History
2023-02-14
10:10 am
Purchase
2022-12-3113GUltragenyx Pharmaceutical Inc.
RARE
RTW INVESTMENTS LP3,966,915
5.700%
3,966,915increase
(New Position)
Filing
History
2023-02-09
11:35 am
Purchase
2022-12-3013GUltragenyx Pharmaceutical Inc.
RARE
The Vanguard Group6,374,230
9.090%
453,662increase
(+7.66%)
Filing
History
2023-02-06
2:58 pm
Purchase
2022-12-3013GUltragenyx Pharmaceutical Inc.
RARE
Wellington Management Group LLP5,202,684
7.420%
3,918,574increase
(+305.16%)
Filing
History
2023-02-03
12:10 pm
Purchase
2022-12-3113GUltragenyx Pharmaceutical Inc.
RARE
BlackRock Inc.
BLK
4,336,492
6.200%
925,078increase
(+27.12%)
Filing
History
2023-01-10
08:47 am
Sale
2022-12-3113GUltragenyx Pharmaceutical Inc.
RARE
FEDERATED HERMES INC.
FHI
3,094,500
4.410%
-892,370decrease
(-22.38%)
Filing
History
2022-12-09
2:31 pm
Sale
2022-12-1213GUltragenyx Pharmaceutical Inc.
RARE
Capital International Investors1,711,517
2.400%
-3,917,936decrease
(-69.60%)
Filing
History
2022-08-10
2:56 pm
Sale
2022-07-3113GUltragenyx Pharmaceutical Inc.
RARE
T. Rowe Price Associates, Inc.5,675,998
8.100%
-5,849,091decrease
(-50.75%)
Filing
History
2022-03-09
5:18 pm
Sale
2022-02-2813GUltragenyx Pharmaceutical Inc.
RARE
BlackRock Inc.
BLK
3,411,414
4.900%
-73,238decrease
(-2.10%)
Filing
History
2022-02-14
3:02 pm
Sale
2021-12-3113GUltragenyx Pharmaceutical Inc.
RARE
FEDERATED HERMES INC.
FHI
3,986,870
5.850%
-293,658decrease
(-6.86%)
Filing
History
Goto 0, 1, Next